ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P TSX Capped Composite...
32.47
(
0.28%
)
US Tech 100
15,700.80
(
0.54%
)
S&P 500
4,604.37
(
0.41%
)
US Dollar vs CAD
1.35925
(
0.05%
)
Bitcoin
42,012.29
(
-4.04%
)
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Emergent Biosolutions Inc (EBS)

  7. Emergent Biosolutions Inc (EBS) News

EBS Emergent Biosolutions Inc

2.39
-0.03 (-1.24%)
Dec 08 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Emergent Biosolutions Inc EBS NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.03 -1.24% 2.39 19:00:00
Open Price Low Price High Price Close Price Previous Close
2.40 2.31 2.60 2.49 2.42
more quote information »

Recent News

Date Time Source Heading
11/28/202306:15EDGAR2Form 8-K - Current report
11/28/202305:59GLOBEEmergent BioSolutions Receives $75 Million Contract Option..
11/24/202306:30GLOBEEmergent BioSolutions Receives NYSE Notice Regarding Delayed..
11/24/202306:17EDGAR2Form 8-K - Current report
11/16/202315:11EDGAR2Form 8-K - Current report
11/14/202318:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202318:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202318:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/09/202315:22EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
11/08/202316:38GLOBEEmergent BioSolutions Reports Third Quarter 2023 Financial..
11/08/202315:21EDGAR2Form 8-K - Current report
10/30/202315:45GLOBEUPDATE: Emergent BioSolutions to Release Third Quarter 2023..
10/19/202305:30GLOBEEmergent BioSolutions to Release Third Quarter 2023..
10/16/202306:00PRNUSEmergent BioSolutions Partners with Emmitt Smith to Launch..
10/05/202318:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/05/202318:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/05/202318:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/05/202318:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/05/202306:42EDGAR2Form 8-K - Current report
10/02/202306:49EDGAR2Form 8-K - Current report
10/02/202306:00GLOBEEmergent BioSolutions Names Two Pharmaceutical Industry..
8/30/202305:30EDGAR2Form 8-K - Current report
8/30/202304:59GLOBEEmergent BioSolutions’ NARCAN® Nasal Spray Launches Over the..
8/21/202317:01PRNUSKenvue Set to Join S&P 500; Advance Auto Parts to Join S&P..
8/16/202315:47EDGAR2Form 8-K - Current report
8/15/202311:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/09/202306:15IHMARKETNEWSWednesday’s Wall Street Highlights: Amazon, Disney, Upstart,..
8/08/202315:31GLOBEEmergent BioSolutions Reports Financial Results for Second..
8/08/202315:12EDGAR2Form 8-K - Current report
8/08/202306:15EDGAR2Form 8-K - Current report
8/08/202306:15GLOBEEmergent BioSolutions Announces Strategic Steps to..
7/31/202316:04DJNEmergent BioSolutions Gets $704 Million Ebola Treatment..
7/31/202315:26EDGAR2Form 8-K - Current report
7/31/202315:05GLOBEEmergent BioSolutions Awarded 10-Year BARDA Contract Valued..
7/27/202315:48EDGAR2Form 8-K - Current report
7/25/202305:30GLOBEEmergent BioSolutions to Release Second Quarter 2023..
7/24/202307:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/24/202307:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/21/202307:25EDGAR2Form 8-K - Current report
7/21/202306:14DJNEmergent BioSolutions Shares Rise 16% After Cyfendus..
7/20/202317:03GLOBEEmergent BioSolutions Receives U.S. FDA Approval of..
6/27/202306:55GLOBEEmergent BioSolutions Announces CEO Transition
5/15/202306:58GLOBEEmergent BioSolutions Finalizes Sale of Travel Health..
5/11/202305:30GLOBEEmergent BioSolutions to Hold Virtual Annual Meeting of..
5/09/202315:05GLOBEEmergent BioSolutions Reports Financial Results For First..
4/19/202315:05GLOBEEmergent BioSolutions to Release First Quarter 2023..
3/29/202308:48GLOBEU.S. FDA Approves Over-the-Counter Designation for Emergent..
3/29/202308:39DJNEmergent BioSolutions Stock Rises 17% on FDA Narcan Approval
2/27/202315:42GLOBEEmergent BioSolutions Reports Financial Results for Fourth..
2/15/202317:22DJNEmergent Bio Shares Up 14% as FDA Panel OKs OTC Narcan Nasal..

Your Recent History

NYSE
EBS
Emergent Biosolutions
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com